Melissa Bonner

946 total citations
21 papers, 519 citations indexed

About

Melissa Bonner is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Melissa Bonner has authored 21 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Genetics and 8 papers in Genetics. Recurrent topics in Melissa Bonner's work include Virus-based gene therapy research (12 papers), CRISPR and Genetic Engineering (8 papers) and Hemoglobinopathies and Related Disorders (6 papers). Melissa Bonner is often cited by papers focused on Virus-based gene therapy research (12 papers), CRISPR and Genetic Engineering (8 papers) and Hemoglobinopathies and Related Disorders (6 papers). Melissa Bonner collaborates with scholars based in United States, France and Thailand. Melissa Bonner's co-authors include John F. Tisdale, Francis J. Pierciey, Mark C. Walters, Alexis A. Thompson, Julie Kanter, Mohammed Asmal, Eric B. Kmiec, Manfred Schmidt, Matthew M. Hsieh and Naoya Uchida and has published in prestigious journals such as Nature Medicine, Blood and Molecular Cancer.

In The Last Decade

Melissa Bonner

21 papers receiving 516 citations

Peers

Melissa Bonner
Angela Rivers United States
Claude Hattab France
Ephrem Chin United States
WB Bias United States
Laura Tonon Italy
René Scholtysik Germany
Hsiao P. J. Voon Australia
Jens Rüschmann Canada
Karen Matta United States
Scott C. Crable United States
Angela Rivers United States
Melissa Bonner
Citations per year, relative to Melissa Bonner Melissa Bonner (= 1×) peers Angela Rivers

Countries citing papers authored by Melissa Bonner

Since Specialization
Citations

This map shows the geographic impact of Melissa Bonner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Bonner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Bonner more than expected).

Fields of papers citing papers by Melissa Bonner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Bonner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Bonner. The network helps show where Melissa Bonner may publish in the future.

Co-authorship network of co-authors of Melissa Bonner

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Bonner. A scholar is included among the top collaborators of Melissa Bonner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Bonner. Melissa Bonner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sailor, Kurt A., Satoru Tada, Béatrix Gillet-Legrand, et al.. (2022). Hematopoietic stem cell transplantation chemotherapy causes microglia senescence and peripheral macrophage engraftment in the brain. Nature Medicine. 28(3). 517–527. 50 indexed citations
2.
Belur, Lalitha R., Kelly M. Podetz-Pedersen, Jessica McKenzie, et al.. (2022). Phenotypic Correction of Murine Mucopolysaccharidosis Type II by Engraftment of Ex Vivo Lentiviral Vector-Transduced Hematopoietic Stem and Progenitor Cells. Human Gene Therapy. 33(23-24). 1279–1292. 11 indexed citations
3.
Leonard, Alexis, John F. Tisdale, & Melissa Bonner. (2022). Gene Therapy for Hemoglobinopathies. Hematology/Oncology Clinics of North America. 36(4). 769–795. 26 indexed citations
4.
Kanter, Julie, Alexis A. Thompson, Francis J. Pierciey, et al.. (2022). Lovo‐cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB‐206 study. American Journal of Hematology. 98(1). 11–22. 63 indexed citations
5.
Bonner, Melissa, Antonio Morales‐Hernández, Sheng Zhou, et al.. (2021). 3’ UTR-truncated HMGA2 overexpression induces non-malignant in vivo expansion of hematopoietic stem cells in non-human primates. Molecular Therapy — Methods & Clinical Development. 21. 693–701. 8 indexed citations
6.
Hongeng, Suradej, Usanarat Anurathapan, Duantida Songdej, et al.. (2021). Wild-type HIV infection after treatment with lentiviral gene therapy for β-thalassemia. Blood Advances. 5(13). 2701–2706. 7 indexed citations
7.
8.
Hsieh, Matthew M., Melissa Bonner, Francis J. Pierciey, et al.. (2020). Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease. Blood Advances. 4(9). 2058–2063. 100 indexed citations
9.
Walters, Mark C., Julie Kanter, Janet L. Kwiatkowski, et al.. (2020). Lentiglobin for Sickle Cell Disease (SCD) Gene Therapy (GT): Updated Results in Group C Patients from the Phase 1/2 Hgb-206 Study. Biology of Blood and Marrow Transplantation. 26(3). S1–S2. 3 indexed citations
10.
Bonner, Melissa, Julie Kanter, Elizabeth R. Macari, et al.. (2019). The Relationships between Target Gene Transduction, Engraftment of HSCs and RBC Physiology in Sickle Cell Disease Gene Therapy. Blood. 134(Supplement_1). 206–206. 6 indexed citations
11.
Yun, Xinwei, Keqiang Zhang, Jinhui Wang, et al.. (2018). Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-Initiating Cells from Lung Adenocarcinoma. Molecular Cancer Research. 16(7). 1161–1171. 29 indexed citations
12.
McKenzie, Jessica, Min Luo, Sean C. Harrington, et al.. (2018). Staurosporine Increases Lentiviral Vector Transduction Efficiency of Human Hematopoietic Stem and Progenitor Cells. Molecular Therapy — Methods & Clinical Development. 9. 313–322. 13 indexed citations
13.
14.
Tisdale, John F., Francis J. Pierciey, Rammurti T. Kamble, et al.. (2017). Successful Plerixafor-Mediated Mobilization, Apheresis, and Lentiviral Vector Transduction of Hematopoietic Stem Cells in Patients with Severe Sickle Cell Disease. Blood. 130(Suppl_1). 990–990. 17 indexed citations
15.
Bonner, Melissa, Christopher Tipper, Holly M. Horton, et al.. (2016). 221. Staurosporine Increases Lentiviral Transduction of Human CD34+ Cells. Molecular Therapy. 24. S86–S87. 1 indexed citations
16.
Heffner, Garrett C., Melissa Bonner, Francis J. Pierciey, et al.. (2016). 229. PGE2 Increases Lentiviral Vector Transduction Efficiency of Human HSC. Molecular Therapy. 24. S89–S90. 3 indexed citations
17.
Bonner, Melissa, Zhijun Ma, Sheng Zhou, et al.. (2015). 81. Development of a Second Generation Stable Lentiviral Packaging Cell Line in Support of Clinical Gene Transfer Protocols. Molecular Therapy. 23. S35–S35. 7 indexed citations
18.
Zhou, Sheng, Melissa Bonner, Yong‐Dong Wang, et al.. (2014). Quantitative Shearing Linear Amplification Polymerase Chain Reaction: An Improved Method for Quantifying Lentiviral Vector Insertion Sites in Transplanted Hematopoietic Cell Systems. Human Gene Therapy Methods. 26(1). 4–12. 11 indexed citations
19.
Bonner, Melissa, et al.. (2012). DNA Damage Response Pathway and Replication Fork Stress During Oligonucleotide Directed Gene Editing. Molecular Therapy — Nucleic Acids. 1. e18–e18. 10 indexed citations
20.
Bonner, Melissa & Eric B. Kmiec. (2009). DNA breakage associated with targeted gene alteration directed by DNA oligonucleotides. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 669(1-2). 85–94. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angela Rivers Breakdown of academic impact, for papers by Claude Hattab Breakdown of academic impact, for papers by Ephrem Chin Breakdown of academic impact, for papers by WB Bias Breakdown of academic impact, for papers by Laura Tonon Breakdown of academic impact, for papers by René Scholtysik Breakdown of academic impact, for papers by Hsiao P. J. Voon Breakdown of academic impact, for papers by Jens Rüschmann Breakdown of academic impact, for papers by Karen Matta Breakdown of academic impact, for papers by Scott C. Crable
Rankless by CCL
2026